Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.29B | 5.47B | 5.19B | 4.71B | 4.35B | 4.30B |
Gross Profit | 2.18B | 2.91B | 2.76B | 2.47B | 2.20B | 2.29B |
EBITDA | 1.69B | 1.84B | 1.70B | 1.34B | 1.12B | 1.27B |
Net Income | 1.12B | 1.25B | 1.14B | 890.80M | 744.05M | 869.79M |
Balance Sheet | ||||||
Total Assets | 7.38B | 8.11B | 7.81B | 7.02B | 6.31B | 5.88B |
Cash, Cash Equivalents and Short-Term Investments | 4.84B | 5.37B | 4.95B | 4.49B | 4.16B | 3.60B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 520.00M | 754.69M | 867.91M | 719.79M | 460.41M | 470.45M |
Stockholders Equity | 6.87B | 7.36B | 6.94B | 6.30B | 5.85B | 5.41B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.20B | 1.24B | 928.87M | 679.75M | 931.47M |
Operating Cash Flow | 0.00 | 1.21B | 1.33B | 1.03B | 763.08M | 960.63M |
Investing Cash Flow | 0.00 | 47.22M | -306.27M | -134.80M | -53.50M | 133.09M |
Financing Cash Flow | 0.00 | -837.87M | -565.36M | -415.97M | -259.98M | -262.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥23.82B | 19.14 | 4.00% | 7.87% | 4.99% | ||
80 Outperform | ¥25.54B | 16.52 | 2.85% | 13.73% | 61.79% | ||
80 Outperform | ¥32.93B | 14.89 | 3.04% | 11.20% | 12.36% | ||
74 Outperform | ¥23.77B | 18.65 | 2.67% | 2.77% | 6.32% | ||
68 Neutral | ¥13.74B | 20.27 | 3.65% | -2.98% | -31.07% | ||
63 Neutral | $33.22B | 5.99 | -11.76% | 1.91% | 5.50% | -19.96% | |
45 Neutral | ¥17.42B | ― | ― | 26.31% | -56.42% |